Literature DB >> 6092613

Genotype-dependent behavioral sensitivity to mu vs. kappa opiate agonists. I. Acute and chronic effects on mouse locomotor activity.

G J Gwynn, E F Domino.   

Abstract

The locomotor activity (LMA) effects of morphine (MRP) and (+/-)-ethylketocyclazocine (EKC) were studied in two inbred mouse strains, C57B1/6J (C57) and DBA/2J (DBA). MRP (3.2-100 mg/kg) caused a monophasic stimulation, a "running fit," in naive C57 mice and a biphasic, depression-stimulation in DBA mice. In contrast, EKC (3.2-100 mg/kg) elicited a biphasic, catalepsy-stereotypy in both strains. The later stereotypic actions of acute EKC, although including sporadic running, were clearly unlike the persistent circling of MRP-stimulation. The LMA responses to MRP and EKC were stereoselective and antagonized by naloxone. Tolerance to the initial depression of activity by MRP in DBA mice developed after chronic administration of either MRP or EKC (32 mg/kg s.c., b.i.d. for 1 week); the intensity of MRP-stimulation, however, increased in both strains. This sensitization to MRP was not overcome with a chronic treatment schedule of 100 mg/kg t.i.d. for 10 days of MRP or EKC. Mice treated chronically with EKC were completely tolerant to its cataleptic and stereotypic effects. Moreover, in these mice EKC elicited a vigorous, MRP-like running fit. Prolonged MRP administration, on the other hand, conferred no tolerance whatsoever to the cataleptic effect of EKC. Taken together with the genetic differences in the acute actions of MRP, this lack of cross-tolerance indicates that distinct neural mechanisms mediate the acute LMA responses to the two narcotics in these mice.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6092613

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  8 in total

1.  A functional polymorphism of the micro-opioid receptor gene is associated with completed suicides.

Authors:  A Hishimoto; H Cui; K Mouri; H Nushida; Y Ueno; K Maeda; O Shirakawa
Journal:  J Neural Transm (Vienna)       Date:  2008-02-04       Impact factor: 3.575

2.  Locomotor responses to benzodiazepines, barbiturates and ethanol in diazepam-sensitive (DS) and -resistant (DR) mice.

Authors:  T J Phillips; E J Gallaher
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

3.  An observational analysis of the effect of the selective kappa opioid agonist, U-50,488H, on feeding and related behaviours in the rat.

Authors:  A Jackson; S J Cooper
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

4.  Csnk1e is a genetic regulator of sensitivity to psychostimulants and opioids.

Authors:  Camron D Bryant; Clarissa C Parker; Lili Zhou; Christopher Olker; Ramalakshmi Y Chandrasekaran; Travis T Wager; Valerie J Bolivar; Andrew S Loudon; Martha H Vitaterna; Fred W Turek; Abraham A Palmer
Journal:  Neuropsychopharmacology       Date:  2011-11-16       Impact factor: 7.853

5.  Role of Efficacy as a Determinant of Locomotor Activation by Mu Opioid Receptor Ligands in Female and Male Mice.

Authors:  Edna J Santos; Matthew L Banks; S Stevens Negus
Journal:  J Pharmacol Exp Ther       Date:  2022-04-30       Impact factor: 4.402

6.  Effects of chronic expression of the HIV-induced protein, transactivator of transcription, on circadian activity rhythms in mice, with or without morphine.

Authors:  Marilyn J Duncan; Annadora J Bruce-Keller; Clayton Conner; Pamela E Knapp; Ruquiang Xu; Avindra Nath; Kurt F Hauser
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-09-10       Impact factor: 3.619

Review 7.  Opioids and behavior: genetic aspects.

Authors:  H R Frischknecht; B Siegfried; P G Waser
Journal:  Experientia       Date:  1988-06-15

8.  Observational analysis of the effects of kappa opioid agonists an open field behaviour in the rat.

Authors:  A Jackson; S J Cooper
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.